Pyridoxine Injection

Name: Pyridoxine Injection
Brand: Artemisine Medicines Technology Co., Ltd.

Injection

Pyridoxine Injection — GMP manufactured injection by Artemisine Medicines Technology. Original manufacturer supply with stable quality, factory direct price and full batch documentation for global markets.

Product Name	Pyridoxine Injection
Dosage Form	Injection
Strength	1 mL / 100 mg
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Injection

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

Treatment and prevention of specific vitamin deficiencies: pyridoxine (B6) in isoniazid-induced neuropathy and pyridoxine-responsive seizures; thiamine (B1) in beriberi, Wernicke's encephalopathy and alcohol-related deficiency; cyanocobalamin (B12) in pernicious/megaloblastic anaemia; vitamin K in bleeding due to deficiency or warfarin reversal.

💧Administration▾

Intramuscular or intravenous injection (thiamine, B12, vitamin K) or oral tablets; thiamine should be given before glucose in malnourished or alcohol-dependent patients.

⚖️Dosage▾

Thiamine 100 mg IV/IM daily (Wernicke's encephalopathy may need higher, protocol-based dosing). Pyridoxine 10–20 mg daily for deficiency; 100–200 mg daily for isoniazid neuropathy. Cyanocobalamin 1,000 mcg IM daily for 1 week, then weekly/monthly. Vitamin K 1–10 mg for coagulation defects.

⚠️Precautions & Warnings▾

Do not delay specific antidotal therapy. Rare anaphylaxis with injectable thiamine — keep resuscitation facilities available. In megaloblastic anaemia, exclude/treat concurrent iron or folate deficiency and confirm the aetiology before long-term replacement.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Pyridoxine Injection — Frequently Asked Questions

Which documents are provided for Pyridoxine Injection registration?

Every batch of Pyridoxine Injection ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Pyridoxine Injection?

MOQ and lead time for Pyridoxine Injection depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Pyridoxine Injection, subject to the regulatory requirements of the destination market.

Which markets have you exported injection products to?

We have supplied injection products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Pyridoxine Injection controlled?

Pyridoxine Injection is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›